Beyond Air Inc. (XAIR)

LungFit^®
Technology

LungFit products use patented Ionizer™ technology that generates unlimited, on-demand nitric oxide using room air. No cylinders and no hassle.

View Our Products

Revolutionizing Nitric Oxide Therapy

Unlocking access to more treatment options from hospital to home.

See Active Pipeline

Latest News

Beyond Cancer Announces Approval by the Israeli Ministry of Health to Conduct a Phase 1b Clinical Trial Utilizing Low Volume Ultra-High Concentration Nitric Oxide (LV UNO) in Combination with Anti-PD-

December 3, 2024

Beyond Cancer Presents Promising Preclinical Data on Low Volume Ultra-High Concentration Nitric Oxide (LV UNO) Therapy at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting

November 11, 2024

Beyond Cancer to Present Preclinical Data of Ultra-High Concentration Nitric Oxide (UNO) Low Volume Therapy at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting

October 7, 2024

Get the Latest

Built on a Legacy of Innovation

Beyond Air is led by a team committed to revolutionizing nitric oxide therapy with the LungFit product family—created by the same inventors who developed the first nitric oxide delivery system and other systems in use worldwide.*

Learn About Us

View Our Corporate Presentation

A paradigm shift for nitric oxide therapy that’s revolutionizing the industry.

*The inventors of the LungFit Systems are also listed as inventors on the patents for the following nitric oxide delivery systems: INOvent, INOmax DS_IR, INOmax DS_IR Plus, INOmax DS_IR Plus MRI.

Caution: LungFit^®PRO and LungFit^®GO are investigational devices, limited by federal (or United States) law to investigational use.

Harnessing the Powerof Nitric Oxide

LungFit® Technology